Results 1 to 10 of about 61,637 (294)
Carbamazepine for schizophrenia [PDF]
Cochrane Database of Systematic Reviews, 2007 Many people with schizophrenia do not achieve a satisfactory treatment response with just antipsychotic drug treatment and various adjunct medications are used to promote additional response. The antiepileptic carbamazepine is one such drug.To evaluate the effects of carbamazepine and its derivatives for the treatment of schizophrenia and related ...
Stefan, Leucht +4 more
openaire +6 more sources
Markedly Elevated Carbamazepine-10,11-epoxide/Carbamazepine Ratio in a Fatal Carbamazepine Ingestion [PDF]
Case Reports in Medicine, 2015 Carbamazepine is a widely used anticonvulsant. Its metabolite, carbamazepine-10,11-epoxide, has been found to display similar anticonvulsant and neurotoxic properties. While the ratio of parent to metabolite concentration varies significantly, at therapeutic doses the epoxide concentration is generally about 20% of the parent. We report a case of fatal
Jason L. Russell +2 more
openaire +3 more sources
Carbamazepine-induced hypogammaglobulinemia [PDF]
Seizure, 2012 Carbamazepine is used to control seizures. Its common side effects are sleep disorders, anorexia, nausea, vomiting, polydipsia, irritability, ataxia, and diplopia. Involvement of the immune system is rare, and few cases of decreased immunoglobulin levels have been reported.
Ozaras, Resat +5 more
openaire +4 more sources
Pharmacogenetics of carbamazepine
Epilepsy and paroxysmal conditions, 2020 Carbamazepine (CMZ) is a drug from the group of anticonvulsants, similar in chemical structure to tricyclic antidepressants. CMZ is widely used for mental disorders and neurological diseases. The lecture discusses the safety of CMZ in respect to personalized medicine, while considering the pharmacogenetic profile of the patient.The authors declare ...
N. A. Shnayder +3 more
openaire +3 more sources
Carbamazepine and Hematological Malignancies [PDF]
The Turkish Journal of Hematology, 2013 Received/Gelis tarihi : May 1, 2013 Accepted/Kabul tarihi : June 10, 2013 To the Editor, The letter entitled “Carbamazepine and Multiple Myeloma: Possible Interaction”, written by Gunaldi et al. [1] and published in one of the recent issues of your journal, was quite interesting. We would like to emphasize some points about that letter. In the reported
Gokhan Sargin +2 more
openaire +3 more sources
Form IV of Carbamazepine [PDF]
Journal of Pharmaceutical Sciences, 2002 Carbamazepine has been found to crystallize as a new polymorph that is stable at room temperature. We report the crystal structure of this C-centered monoclinic form (space group C2/c, cell parameters: a = 26.609, b = 6.9269, c = 13.957, beta = 109.702), which consists of hydrogen bonded dimers with an anti-disposition.
Lang, Meidong +2 more
openaire +4 more sources
Personalizing carbamazepine therapy [PDF]
Genome Medicine, 2011 The anticonvulsant carbamazepine has a high incidence of cutaneous adverse drug reactions. A recent prospective clinical trial in Taiwan has indicated that HLA-B*1502 screening will reduce the incidence of life-threatening adverse reactions to carbamazepine, while a genome-wide association study has identified the HLA-A*3101 allele as a genetic risk ...
Yusuke Nakamura, Taisei Mushiroda
openaire +3 more sources
Carbamazepine‐Induced Tics [PDF]
Epilepsia, 1993 Summary:A variety of movement disorders are known to occur in association with carbamazepine (CBZ) therapy in adults and children, but development of tics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
Robertson, Patricia L. +3 more
openaire +4 more sources
Teratogenicity of Carbamazepine
Pediatric Neurology Briefs, 2001 The teratogenic risk after first trimester exposure to carbamazepine was determined from 210 pregnancies followed prospectively at the Israeli Teratogen Information Service, and Laboratory of Teratology, Hebrew University, Hadassah Medical School, and Ministry of Health, Jerusalem, Israel.
openaire +4 more sources
Carbamazepine: A Therapy for ADHD
Pediatric Neurology Briefs, 1996 The efficacy of carbamazepine (CBZ) in treatment of ADHD has been determined by meta-analysis of 10 reports from the international literature reviewed at Columbia University, St Lukes-Roosevelt Hospital Center, and New York University Medical Center.
openaire +4 more sources